Home › Research › Caregiving
Global incidence trends and projections of Alzheimer disease and other dementias: an age-period-cohort analysis 2021
Libo Xu, Zhenhao Wang, Mao Li, Qingsong Li. Journal of Global Health, 2025-05-23
Topic: Risk, prevention and care in population studies
Plain-language summary
Between 1992-2021, global AD cases increased from 4.078 million to 9.837 million, while the global age-standardised incidence rate (ASIR) remained relatively stable, rising slightly from 117.7 to 119.8 per 100 000. ASIR increased significantly in high-middle and middle-sociodemographic index regions, but declined in the low-sociodemographic index regions. Women consistently exhibited higher incidence rates than men across all regions. Projections indicate that 2036 global AD cases will reach 19.117 million, with an ASIR of 418.92 per 100 000. While global ASIR has remained stable, the number of AD cases continues to rise due to population ageing, particularly in middle- and high-income regions. Low-income regions face additional challenges due to limited health care resources. Gender disparities and unequal access to health care contribute to the variations in disease burden. These findings emphasise the need to prioritise early diagnosis and implement targeted interventions to reduce future disease burdens and address global health care inequalities.
What this study adds
Evidence grade: Moderate
This analysis of global data found that Alzheimer disease cases rose from 4.078 million in 1992 to 9.837 million in 2021 while the age-standardised incidence rate stayed relatively stable, and projects 19.117 million cases by 2036. It is descriptive and projection-based, and the authors emphasise the need for early diagnosis and targeted interventions rather than reporting a treatment or cure.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Xu, L., Wang, Z., Li, M., & Li, Q. (2025). Global incidence trends and projections of Alzheimer disease and other dementias: an age-period-cohort analysis 2021. Journal of Global Health. https://doi.org/10.7189/jogh.15.04156
Vancouver
Xu L, Wang Z, Li M, Li Q. Global incidence trends and projections of Alzheimer disease and other dementias: an age-period-cohort analysis 2021. Journal of Global Health. 2025. doi:10.7189/jogh.15.04156. PMID: 40406980.
BibTeX
@article{xu2025-40406980,
author = {Xu, Libo and Wang, Zhenhao and Li, Mao and Li, Qingsong},
title = {{Global incidence trends and projections of Alzheimer disease and other dementias: an age-period-cohort analysis 2021}},
journal = {Journal of Global Health},
year = {2025},
doi = {10.7189/jogh.15.04156},
pmid = {40406980},
url = {https://doi.org/10.7189/jogh.15.04156}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Between 1992-2021, global AD cases increased from 4.078 million to 9.837 million, while the global age-standardised incidence rate (ASIR) remained relatively stable, rising slightly from 117.7 to 119.8 per 100 000.
- ASIR increased significantly in high-middle and middle-sociodemographic index regions, but declined in the low-sociodemographic index regions.
- Women consistently exhibited higher incidence rates than men across all regions.
- Projections indicate that 2036 global AD cases will reach 19.117 million, with an ASIR of 418.92 per 100 000.
- While global ASIR has remained stable, the number of AD cases continues to rise due to population ageing, particularly in middle- and high-income regions.
Why it matters
This analysis of global data found that Alzheimer disease cases rose from 4.078 million in 1992 to 9.837 million in 2021 while the age-standardised incidence rate stayed relatively stable, and projects 19.117 million cases by 2036. It is descriptive and projection-based, and the authors emphasise the need for early diagnosis and targeted interventions rather than reporting a treatment or cure.
New to this subject? Start with our plain-English guide: Caregiving →
Study details
- Evidence strengthModerate
How this study scored 48/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of Global Health) |
| Journal's citation record | 1 / 4 | Journal of Global Health: journal h-index 93 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 41 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 13.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 5 / 6 | Cited 26.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 2 / 4 | Cited 41 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Qingsong Li: h-index 40 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of California, Davis: institution h-index 1,257 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40406980) |
| Free to read | 2 / 2 | Free to read |
| Total | 48 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.7189/jogh.15.04156
- PubMed: 40406980
- Original source →
- Free full text: Journal of Global Health →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Caregiving from nearby years
Also tagged “prevalence”
1,225 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,225 tagged studies.